NM_032447.5:c.6603T>C
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_032447.5(FBN3):c.6603T>C(p.Asp2201Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.71 in 1,613,476 control chromosomes in the GnomAD database, including 411,406 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.75 ( 43759 hom., cov: 31)
Exomes 𝑓: 0.71 ( 367647 hom. )
Consequence
FBN3
NM_032447.5 synonymous
NM_032447.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.492
Publications
16 publications found
Genes affected
FBN3 (HGNC:18794): (fibrillin 3) This gene encodes a memebr of the fibrillin protein family. Fibrillins are extracellular matrix molecules that assemble into microfibrils in many connective tissues. This gene is most highly expressed in fetal tissues and its protein product is localized to extracellular microfibrils of developing skeletal elements, skin, lung, kidney, and skeletal muscle. This gene is potentially involved in Weill-Marchesani syndrome. [provided by RefSeq, Mar 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 19-8087841-A-G is Benign according to our data. Variant chr19-8087841-A-G is described in ClinVar as Benign. ClinVar VariationId is 1603105.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.492 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.895 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.751 AC: 114034AN: 151884Hom.: 43698 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
114034
AN:
151884
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.681 AC: 171020AN: 251266 AF XY: 0.677 show subpopulations
GnomAD2 exomes
AF:
AC:
171020
AN:
251266
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.706 AC: 1031566AN: 1461474Hom.: 367647 Cov.: 44 AF XY: 0.702 AC XY: 510257AN XY: 727080 show subpopulations
GnomAD4 exome
AF:
AC:
1031566
AN:
1461474
Hom.:
Cov.:
44
AF XY:
AC XY:
510257
AN XY:
727080
show subpopulations
African (AFR)
AF:
AC:
30386
AN:
33476
American (AMR)
AF:
AC:
29290
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
19020
AN:
26134
East Asian (EAS)
AF:
AC:
19589
AN:
39696
South Asian (SAS)
AF:
AC:
49047
AN:
86256
European-Finnish (FIN)
AF:
AC:
34905
AN:
53386
Middle Eastern (MID)
AF:
AC:
4135
AN:
5758
European-Non Finnish (NFE)
AF:
AC:
802233
AN:
1111664
Other (OTH)
AF:
AC:
42961
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
15300
30601
45901
61202
76502
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
19852
39704
59556
79408
99260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.751 AC: 114143AN: 152002Hom.: 43759 Cov.: 31 AF XY: 0.741 AC XY: 55050AN XY: 74268 show subpopulations
GnomAD4 genome
AF:
AC:
114143
AN:
152002
Hom.:
Cov.:
31
AF XY:
AC XY:
55050
AN XY:
74268
show subpopulations
African (AFR)
AF:
AC:
37451
AN:
41512
American (AMR)
AF:
AC:
10821
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
AC:
2545
AN:
3470
East Asian (EAS)
AF:
AC:
2539
AN:
5138
South Asian (SAS)
AF:
AC:
2516
AN:
4816
European-Finnish (FIN)
AF:
AC:
6809
AN:
10540
Middle Eastern (MID)
AF:
AC:
221
AN:
294
European-Non Finnish (NFE)
AF:
AC:
49081
AN:
67938
Other (OTH)
AF:
AC:
1603
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1358
2717
4075
5434
6792
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
832
1664
2496
3328
4160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1844
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.